Articles by author - Sema Yarman

Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas.

Yarman S, Kurtulmus N, Bilge A.

Journal Article 2012; 33(3): 340-346 PubMed PMID: 22635095  Keywords:  Adult, Aged, Bromocriptine:administration & dosage, Dopamine Agonists:administration & dosage, Dose-Response Relationship, Drug, Ergolines:administration & dosage, Female, Heart Valve Diseases:chemically induced, Humans, Male, Middle Aged, Pituitary Neopl.    Citation

OBJECTIVES: Prolactinoma is the most common pituitary adenoma, and dopamine agonists( BRC, and CAB) is the primary therapy. Recently, the .....

Read abstract  Full text PDF

Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior ?

Yarman S, Kurtulmus N, Canbolat A, Bayindir C, Bilgic B, Ince N.

Journal Article 2010; 31(6): 823-828 PubMed PMID: 21196926  Keywords:  Acromegaly:etiology, Adenoma:complications, Adult, Aged, Biomarkers, Tumor:metabolism, Early Diagnosis, Female, Growth Hormone-Secreting Pituitary Adenoma:complications, Humans, Immunohistochemistry, Ki-67 Antigen:metabolism, Male, Middle Aged, Neoplasm I.    Citation

OBJECTIVE: In many pituitary tumor, immunohistochemical studies have been shown to be correlated with different aspects of tumor behavior......

Read abstract  Full text PDF